|
|
|
|
Дата |
|---|
| 05.02.2026 |
| 04.02.2026 |
| 03.02.2026 |
| 02.02.2026 |
| 30.01.2026 |
| 29.01.2026 |
| 28.01.2026 |
| 27.01.2026 |
| 26.01.2026 |
| 23.01.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
235.50
|
228.00
|
235.50
|
229.00
|
|
|
2 156 159.25
|
|
|
|
|
240.00
|
231.50
|
240.00
|
232.00
|
|
|
1 944 441.75
|
|
|
|
|
238.50
|
237.00
|
241.50
|
238.00
|
|
|
1 465 269.50
|
|
|
|
|
239.00
|
237.00
|
241.00
|
238.00
|
|
|
907 892.25
|
|
|
|
|
242.50
|
238.00
|
243.50
|
240.00
|
|
|
428 469.00
|
|
|
|
|
243.00
|
241.00
|
244.00
|
241.50
|
|
|
775 115.00
|
|
|
|
|
244.00
|
240.50
|
244.00
|
240.50
|
|
|
2 588 708.50
|
|
|
|
|
245.00
|
240.50
|
245.50
|
240.50
|
|
|
1 066 504.00
|
|
|
|
|
245.00
|
241.00
|
245.00
|
244.50
|
|
|
780 677.00
|
|
|
|
|
242.50
|
241.00
|
244.50
|
244.00
|
|
|
993 907.50
|
|
Период |
|---|
| 2023, регулярные |
| 2022, регулярные |
| 2021, регулярные |
| 2021, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
07.08.2024
|
08.08.2024 |
7.5 CHF |
|
03.08.2023
|
04.08.2023 |
7.5 CHF |
|
30.08.2022
|
31.08.2022 |
9.7 CHF |
|
07.09.2021
|
08.09.2021 |
12.5 CHF |
|
08.09.2020
|
09.09.2020 |
7.7 CHF |
|
10.09.2019
|
11.09.2019 |
7.5 CHF |
|
19.09.2018
|
20.09.2018 |
1.5 CHF |
|
27.06.2018
|
28.06.2018 |
5.5 CHF |
|
28.06.2017
|
29.06.2017 |
5.8 CHF |
|
28.06.2016
|
29.06.2016 |
5.5 CHF |
HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of some twenty five promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).
